Ataxia Telangiectasia Mutated (ATM) Signaling Network Is Modulated by a Novel Poly(ADP-ribose)-dependent Pathway in the Early Response to DNA-damaging Agents
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribosyl)ation is a post-translational modification that is instantly stimulated by DNA strand breaks creating a unique signal for the modulation of protein functions in DNA repair and cell cycle checkpoint pathways. Here we report that lack of poly(ADP-ribose) synthesis leads to a compromised response to DNA damage. Deficiency in poly(ADP-ribosyl)ation metabolism induces profound cellular sensitivity to DNA-damaging agents, particularly in cells deficient for the protein kinase ataxia telangiectasia mutated (ATM). At the biochemical level, we examined the significance of poly(ADP-ribose) synthesis on the regulation of early DNA damage-induced signaling cascade initiated by ATM. Using potent PARP inhibitors and PARP-1 knock-out cells, we demonstrate a functional interplay between ATM and poly(ADP-ribose) that is important for the phosphorylation of p53, SMC1, and H2AX. For the first time, we demonstrate a functional and physical interaction between the major DSB signaling kinase, ATM and poly(ADP-ribosyl)ation by PARP-1, a key enzyme of chromatin remodeling. This study suggests that poly(ADP-ribose) might serve as a DNA damage sensory molecule that is critical for early DNA damage signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This finding is consistent with published studies in which loss of MRN (2), Tip60 (4, 6), or acute PARP inhibition (35) led to defective activation of ATM's kinase activity.”
From DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin (2014) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Finally, depletion of suv39h1 increased cell sensitivity to PARPi (Fig. 6D), consistent with previous reports that cells lacking ATM are sensitive to PARP inhibition (34,35).”
From DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin (2014) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70
Sawada, M., Hayes, P., & Matsuyama, S. (2003) · Nature Cell Biology · doi:10.1038/ncb955 · Cited by 161
RetractedTargeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Białkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0140 · Cited by 1,310
Post‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,079
Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal
Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 802
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.
Wang, Z. Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M., & Wagner, E. F. (1995) · Genes & Development · doi:10.1101/gad.9.5.509 · Cited by 774
Direct Activation of the ATM Protein Kinase by the Mre11/Rad50/Nbs1 Complex
Lee, J.-H., & Paull, T. T. (2004) · Science · doi:10.1126/science.1091496 · Cited by 762
Cited by
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
“treatment with DNA-damaging agents (Haince et al., 2007).”
BackgroundThe multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Ray Chaudhuri, A., & Nussenzweig, A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.53 · Cited by 1,786
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
“The observation that rapid recruitment of mitotic recombination 11 ( MRE11 ) and ataxia telangiectasia-mutated ( ATM ), crucial components of the homologous recombination machinery, to DNA DSBs is dependent on pADPr synthesi”
BackgroundSelf-citationNAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
Roos, W. P., & Kaina, B. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.01.007 · Cited by 879
“It is possible that PARP-1 (poly(ADP-ribose) polymerase) is also involved as indicated by some recent data [86].”
BackgroundPARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681
“…recruitment to DNA damage sites of mitotic recombination 11 (MRE11) (Haince et al. 2008) and ataxia telangiectasia-mutated (ATM) (Aguilar-Quesada et al. 2007; Haince et al. 2007), components of the homologous recombinationmachinery, implicates PARP-1 in homologous recombination as well.”
BackgroundPARP1-dependent Kinetics of Recruitment of MRE11 and NBS1 Proteins to Multiple DNA Damage Sites
Haince, J.-F., McDonald, D., Rodrigue, A., Déry, U., Masson, J.-Y., Hendzel, M. J., & Poirier, G. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706734200 · Cited by 608
Self-citationThe diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
De Vos, M., Schreiber, V., & Dantzer, F. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.03.018 · Cited by 492
Inflammation-induced DNA damage, mutations and cancer
Kay, J., Thadhani, E., Samson, L., & Engelward, B. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.102673 · Cited by 464
Gagné, J.-P., Isabelle, M., Lo, K. S., Bourassa, S., Hendzel, M. J., Dawson, V. L., Dawson, T. M., & Poirier, G. G. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn771 · Cited by 414
Self-citationJungmichel, S., Rosenthal, F., Altmeyer, M., Lukas, J., Hottiger, M. O., & Nielsen, M. L. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.026 · Cited by 373
Ayrapetov, M. K., Gursoy-Yuzugullu, O., Xu, C., Xu, Y., & Price, B. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403565111 · Cited by 391
“This finding is consistent with published studies in which loss of MRN (2), Tip60 (4, 6), or acute PARP inhibition (35) led to defective activation of ATM’s kinase activity.”
BackgroundResultPoly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
Scott, C. L., Swisher, E. M., & Kaufmann, S. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8848 · Cited by 355
Thompson, L. H. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.06.002 · Cited by 357
PARP-1 and its associated nucleases in DNA damage response
Wang, Y., Luo, W., & Wang, Y. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.102651 · Cited by 272
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Zhu, H., Wei, M., Xu, J., Hua, J., Liang, C., Meng, Q., Zhang, Y., Liu, J., Zhang, B., Yu, X., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01167-9 · Cited by 252
ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy
Rodríguez-Vargas, J. M., Ruiz-Magaña, M. J., Ruiz-Ruiz, C., Majuelos-Melguizo, J., Peralta-Leal, A., Rodríguez, M. I., Muñoz-Gámez, J. A., de Almodóvar, M. R., Siles, E., Rivas, A. L., et al. (2012) · Cell Research · doi:10.1038/cr.2012.70 · Cited by 250
The role of poly ADP-ribosylation in the first wave of DNA damage response
Liu, C., Vyas, A., Kassab, M. A., Singh, A. K., & Yu, X. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx565 · Cited by 240
“Consistently, the early recruitment of MER11 and NBS1 is mediated by PARP1 (26,49).”
BackgroundTherapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy
Kim, B., Hong, Y., Lee, S., Liu, P., Lim, J., Lee, Y., Lee, T., Chang, K., & Hong, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125991 · Cited by 234
“Although the mechanisms by which PARP contributes to NHEJ and HR are not as well defined as in BER and SSB repair, PARP has been shown to interact with DSB repair proteins such as NBS1, Mre11, Ku80, DNA–PKcs, and ATM [112–115].”
BackgroundRole of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
Faraoni, I., & Graziani, G. (2018) · Cancers · doi:10.3390/cancers10120487 · Cited by 232
A nuclear poly(ADP-Ribose)-dependent signalosome confers DNA damage-induced IκB kinase activation.
Stilmann, M., Hinz, M., Arslan, S. Ç., Zimmer, A., Schreiber, V., & Scheidereit, C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.032 · Cited by 232
“Since ATM also contains PARBMs (Figures 4C and 4D) (Haince et al., 2007), it is likely that PAR chains contribute to its signalosome recruitment as well.”
BackgroundMethodResultInfluentialMansour, W. Y., Rhein, T., & Dahm-Daphi, J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq387 · Cited by 211
“Recruitment of PARP1 to sites of DNA damage and subsequent poly-(ADP)ribosylation of target proteins, including itself, is a rapid process starting within seconds and implicates PARP1 in the ATM-mediated DNA damage response (37,58,59).”
BackgroundSulfur mustard toxicity: History, chemistry, pharmacokinetics, and pharmacodynamics
Ghabili, K., Agutter, P. S., Ghanei, M., Ansarin, K., Panahi, Y., & Shoja, M. M. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.541224 · Cited by 213
“, 1998; Paull and Gellert, 1999); ATM is up-regulated by poly(ADP-ribose) (Haince et al., 2007).”
BackgroundFunctional Aspects of PARP1 in DNA Repair and Transcription
Ko, H. L., & Ren, E. C. (2012) · Biomolecules · doi:10.3390/biom2040524 · Cited by 206
ATM Activation and Signaling under Hypoxic Conditions
Bencokova, Z., Kaufmann, M. R., Pires, I. M., Lecane, P. S., Giaccia, A. J., & Hammond, E. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01301-08 · Cited by 203
“This is also supportive of a model whereby hypoxia induces ATM activity in the absence of DNA breaks and hence is not reliant on molecules which act as sensors of breaks (24).”
BackgroundPARP inhibitor combination therapy
Dréan, A., Lord, C. J., & Ashworth, A. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.10.010 · Cited by 212
Poly(ADP-ribose): PARadigms and PARadoxes
Bürkle, A., & Virág, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.010 · Cited by 195
“…substrates such as p53, SMC1, and H2AX was reduced by the PARP inhibitor PJ34 ATM-deficiency has no effect on PAR synthesis of MNNG-treated cells Haince et al. (2007) ATM Purified PAR (and other charged molecules such as ssDNA, sheared doublestranded calf thymus DNA, heparin sulfate) activates…”
BackgroundGodon, C., Cordelieres, F. P., Biard, D., Giocanti, N., Megnin-Chanet, F., Hall, J., & Favaudon, V. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn403 · Cited by 186
Liao, H., Ji, F., Helleday, T., & Ying, S. (2018) · EMBO reports · doi:10.15252/embr.201846263 · Cited by 187
“It is also reported that PARP1 facilitates DSB repair by promoting recruitment of HR proteins including MRE11, ATM and BRCA1 [134,138,139].”
Primary Immunodeficiency Diseases in Norway
Stray-Pedersen, A., Abrahamsen, T. G., & Frøland, S. S. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1026416017763 · Cited by 194
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
Williamson, C. T., Muzik, H., Turhan, A. G., Zamò, A., O'Connor, M. J., Bebb, D. G., & Lees-Miller, S. P. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0872 · Cited by 193
“Although ablation of ATM through RNA interference (9), genetic means (12, 13, 22), or inhibition of ATM kinase activity using a small-molecule”
MethodReprogramming cellular events by poly(ADP-ribose)-binding proteins
Krietsch, J., Rouleau, M., Pic, É., Ethier, C., Dawson, T. M., Dawson, V. L., Masson, J.-Y., Poirier, G. G., & Gagné, J.-P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.005 · Cited by 169
Self-citationHu, Y., Petit, S. A., Ficarro, S. B., Toomire, K. J., Xie, A., Lim, E., Cao, S. A., Park, E., Eck, M. J., Scully, R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0891 · Cited by 167
“11 begins with a cluster of basic residues followed by a pattern of hydrophobic amino acids interspersed with basic residues (43-45).”
Toward specific functions of poly(ADP-ribose) polymerase-2
Yélamos, J., Schreiber, V., & Dantzer, F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.003 · Cited by 165
Alpatov, R., Lesch, B. J., Nakamoto-Kinoshita, M., Blanco, A., Chen, S., Stützer, A., Armache, K. J., Simon, M. D., Xu, C., Ali, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.03.040 · Cited by 165
“Our finding is consistent with published observations, including the report that FMRP interacts with poly(ADP-ribose) glycohydrolase (PARG) and poly (ADP-ribose) polymerase (PARP), which are major modulators of genomic stability (Gagné et al., 2005; Isabelle et al., 2010, Ciccia and Elledge, 2010; Haince et al., 2007).”
BackgroundResultSynthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
Esposito, M. T., Zhao, L., Fung, T. K., Rane, J. K., Wilson, A., Martin, N., Gil, J., Leung, A. Y., Ashworth, A., & Eric So, C. W. (2015) · Nature Medicine · doi:10.1038/nm.3993 · Cited by 167
Fahrer, J., Kranaster, R., Altmeyer, M., Marx, A., & Bürkle, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm944 · Cited by 161
“Very recently a physical and functional interplay of protein kinase Ataxia telangiectasia mutated (ATM), which is involved in the early DNA damage response, and PAR has been established (25).”
BackgroundPoly(ADP-ribose) makes a date with death
Heeres, J. T., & Hergenrother, P. J. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.038 · Cited by 158
“More recently, the DNA-damage responsive kinase ATM was added to the list of PAR-binding proteins [7].”
BackgroundTargeting the DNA Damage Response in Cancer
Ljungman, M. (2009) · Chemical Reviews · doi:10.1021/cr900047g · Cited by 163
PARP Inhibitor Treatment in Ovarian and Breast Cancer
Weil, M. K., & Chen, A. P. (2011) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2010.12.002 · Cited by 162
“[34–35] (Fig.”
PARPs and the DNA damage response
Sousa, F. G., Matuo, R., Soares, D. G., Escargueil, A. E., Henriques, J. A. P., Larsen, A. K., & Saffi, J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs132 · Cited by 154
CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage
Ismail, I. H., Gagné, J., Caron, M., McDonald, D., Xu, Z., Masson, J., Poirier, G. G., & Hendzel, M. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks222 · Cited by 157
“anionic poly(ADP-ribose) matrix that triggers local chromatin relaxation while acting as a loading platform for a variety of DDR factors (46).”
BackgroundSelf-citationJain, P. G., & Patel, B. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.024 · Cited by 142
Radiation-induced mitotic catastrophe in PARG-deficient cells
Amé, J., Fouquerel, E., Gauthier, L., Biard, D. S. F., Boussin, F. D., Dantzer, F., de MURCIA, G., & Schreiber, V. (2009) · Journal of Cell Science · doi:10.1242/jcs.039115 · Cited by 139
“In addition, a functional interplay between PARP1 activity and ATM activity has been reported (Aguilar-Quesada et al., 2007; Haince et al., 2007), supporting the correlation between PAR accumulation and ATM activation observed in PARG-depleted cells.”
BackgroundThe synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
Li, S., Wang, L., Wang, Y., Zhang, C., Hong, Z., & Han, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01360-x · Cited by 150
“PARP1 senses DSBs and recruits factors, such as ATM and meiotic recombination 11 homolog 1 (MRE11), which interacts with PARPbinding domains to repair the breaks [56, 57].”
BackgroundLiu, S. K., Coackley, C. L., Krause, M., Jalali, F., Chan, N. H. L., & Bristow, R. G. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.04.005 · Cited by 136
van Beek, L., McClay, É., Patel, S., Schimpl, M., Spagnolo, L., & de Oliveira, T. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105112 · Cited by 143
Yin, H., & Glass, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024080 · Cited by 140
“In response to double strand DNA damage, ATM is activated through autophosphorylation at several residues including Ser1981 and by poly(ADP-ribosyl)ation by PARP protein [38].”
BackgroundMangerich, A., & Bürkle, A. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/321653 · Cited by 122
“Here, we review the molecular mechanisms underlying the various roles of PARP1 in longevity and aging with special emphasis on cellular studies and we briefly discuss the results in the context of in vivo studies in mice and humans.”
BackgroundYin, L., Liu, Y., Peng, Y., Peng, Y., Yu, X., Gao, Y., Yuan, B., Zhu, Q., Cao, T., He, L., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0810-7 · Cited by 140
Min, W., Bruhn, C., Grigaravičius, P., Zhou, Z., Li, F., Krüger, A., Siddeek, B., Greulich, K., Popp, O., Meisezahl, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3993 · Cited by 142
Kubota, E., Williamson, C. T., Ye, R., Elegbede, A., Peterson, L., Lees-Miller, S. P., & Bebb, D. G. (2014) · Cell Cycle · doi:10.4161/cc.29212 · Cited by 124
“Moreover, inactivation of ATM together with PARP-1 in mice is embryonic lethal,(21) and synthetic lethality between PARP and ATM has been reported in cells from patients with ataxia telangiectasia, a cancer predisposition syndrome associated with loss of both ATM alleles.(22) Based on these observations, we”
BackgroundPARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?
Swindall, A. F., Stanley, J. A., & Yang, E. S.-H. (2013) · Cancers · doi:10.3390/cancers5030943 · Cited by 140
“It has been shown that PARP-1 interacts with several proteins involved in the DSB repair pathways including NBS1, Mre11, Ku80, DNA-PKcs and ATM [24–27].”
ATM protein kinase: the linchpin of cellular defenses to stress
Bhatti, S., Kozlov, S., Farooqi, A. A., Naqi, A., Lavin, M., & Khanna, K. K. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0683-9 · Cited by 116
“Haince et al. (2007) [59] demonstrated the existence of a specific PAR-binding domain spanning amino acids 99–120 of ATM.”
BackgroundSelf-citationDe Lorenzo, S. B., Patel, A. G., Hurley, R. M., & Kaufmann, S. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00228 · Cited by 111
Dungey, F. A., Caldecott, K. W., & Chalmers, A. J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0201 · Cited by 113
“This and other studies have described inhibition of a range of DNA damage responses including ataxia telangiectasia mutated (ATM) activation (24, 25) and base excision repair function (25).”
InfluentialStrickfaden, H., McDonald, D., Kruhlak, M. J., Haince, J.-F., Th'ng, J. P. H., Rouleau, M., Ishibashi, T., Corry, G. N., Ausió, J., Underhill, D. A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694992 · Cited by 120
“ATM and MRE11 both have a functional PAR binding domain that is important for their function in the DNA damage response, which suggests that PAR deposition at DSBs is likely involved in the efficient recruitment of these repair mediators (7, 11, 12).”
BackgroundSelf-citationCho, S. H., Goenka, S., Henttinen, T., Gudapati, P., Reinikainen, A., Eischen, C. M., Lahesmaa, R., & Boothby, M. (2009) · Blood · doi:10.1182/blood-2008-03-144121 · Cited by 106
ATM prevents DSB formation by coordinating SSB repair and cell cycle progression
Khoronenkova, S. V., & Dianov, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416031112 · Cited by 123
“Recently, it has become evident that ATM is also activated by a number of DNA-damaging agents that cause base oxidation (9, 10) and alkylation (11, 12).”
BackgroundPoly(ADP-ribosyl)ation in mammalian ageing
Beneke, S., & Burkle, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm735 · Cited by 106
“It was shown recently that the activity of another PIKK-member, ATM (ataxia telangiectasia mutated), is positively modulated by PAR (67).”
BackgroundDörsam, B., Seiwert, N., Foersch, S., Stroh, S., Nagel, G., Begaliew, D., Diehl, E., Kraus, A., McKeague, M., Minneker, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712345115 · Cited by 105
“PARP-1 is also engaged in lesion sensing by recruiting ATM and MRN to sites of DNA double-strand breaks (DSBs) and of stalled replication forks (12, 13).”
BackgroundO'Sullivan, C. C., Moon, D. H., Kohn, E. C., & Lee, J. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00042 · Cited by 119
“In PARP1-deficient cells, ATM-kinase function is compromised leading to a reduction in DNA DSB in response to radiation, indicating a role of PARP1 in ATM activation and HR (38, 41).”
BackgroundRegulation of chromatin structure by poly(ADP-ribosyl)ation
Beneke, S. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00169 · Cited by 98
“Increased poly(ADP-ribosyl)ation (PARylation) metabolism is one of the first cellular responses following exposure to genotoxic stress (Haince et al., 2007, 2008).”
BackgroundDestabilization of linker histone H1.2 is essential for ATM activation and DNA damage repair
Li, Z., Li, Y., Tang, M., Peng, B., Lu, X., Yang, Q., Zhu, Q., Hou, T., Li, M., Liu, C., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0048-0 · Cited by 102
“Deletion or inhibition of PARP1 results in hypersensitivity to DNA damage inducers and compromised ATM activation.(19,57,58) PARP1 modifies a set of proteins via the addition of ADP-ribose moieties to its substrates to alter protein–protein or protein–DNA interactions.”
BackgroundThe role of poly(ADP-ribosyl)ation in epigenetic events
Quénet, D., Ramy, R. E., Schreiber, V., & Dantzer, F. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.023 · Cited by 113
Baritaud, M., Cabon, L., Delavallée, L., Galán‐Malo, P., Me, G., Brunelle-Navas, M.-N., & Susín, S. A. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.120 · Cited by 109
“In our paradigm, it may be interesting to analyze whether the changes in chromatin structure provoked by the treatment of MEFs with the nitrosourea MNNG may directly activate ATM or whether even PARP-1 may directly activate ATM, as has been suggested in other PCD programs.(40) In the case of DNAPK, its function and ac…”
BackgroundThe potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
Javle, M., & Curtin, N. J. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011417039 · Cited by 92
“PARP activity also promotes the activation of mitotic recombination 11 (MRE11) and Nijmegen breakage syndrome (NBS), members of the DNA damage-sensing MRN complex which activates ATM to sites of double-stand DNA damage [Haince et al. 2007].”
BackgroundPoly-ADP-ribose polymerase: Machinery for nuclear processes
Thomas, C. J., & Tulin, A. V. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.04.001 · Cited by 105
“(Du et al. 2006; Haince et al. 2007).”
Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing
Ji, Y., & Tulin, A. V. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp218 · Cited by 88
Farrar, D., Rai, S., Chernukhin, I., Jagodic, M., Ito, Y., Yammine, S., Ohlsson, R., Murrell, A., & Klenova, E. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00827-09 · Cited by 88
“Functional regulation by both modifications, PARylation and phosphorylation, is not unusual and has been reported previously for p53 and histones (30, 41, 70).”
BackgroundKanev, P.-B., Atemin, A., Stoynov, S., & Aleksandrov, R. (2023) · Seminars in Oncology · doi:10.1053/j.seminoncol.2023.08.001 · Cited by 100
Esposito, M. T., & So, C. W. E. (2014) · Chromosoma · doi:10.1007/s00412-014-0482-9 · Cited by 96
“2008) and recruitment of ATM to damaged DNA (Haince et al. 2007).”
BackgroundSUMOylation and de‐SUMOylation in response to DNA damage
Dou, H., Huang, C., Nguyen, T. V., Lu, L., & Yeh, E. T. H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.002 · Cited by 96
“MmRAD52 / ES cells are also not hypersensitive to agents that induce DSBs.”
BackgroundInfluentialThe role of PARP1 in the DNA damage response and its application in tumor therapy
Wang, Z., Wang, F., Tang, T.-S., & Guo, C. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0197-3 · Cited by 97
“Once recruited to SSBs, PARP1 will be activated within a few minutes [18] and immediately transfer PARs to itself and other targeting proteins.”
BackgroundMethodInfluentialHow to kill tumor cells with inhibitors of poly(ADP‐ribosyl)ation
Mangerich, A., & Bürkle, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25683 · Cited by 84
CHFR is important for the first wave of ubiquitination at DNA damage sites
Liu, C., Wu, J., Paudyal, S. C., You, Z., & Yu, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1278 · Cited by 91
Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments
Wu, X., Qin, L., Fako, V., & Zhang, J.-T. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.004 · Cited by 82
“…excision repair, mismatch repair, and double-strand break repair by homologous recombination and non-homologous end joining (Bryant et al., 2009, Dantzer et al., 2000, Fu et al., 2012, Gagne et al., 2008, Haince et al., 2007, Hegde et al., 2008, Khodyreva et al., 2010, Pleschke et al, 2000).”
BackgroundNicotinamide adenine dinucleotide: beyond a redox coenzyme
Lin, H. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b706887e · Cited by 98
Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair
Van Meter, M., Mao, Z., Gorbunova, V., & Seluanov, A. (2011) · Aging · doi:10.18632/aging.100389 · Cited by 80
“Haince JF, Kozlov S, Dawson VL, Dawson TM, Hendzel MJ, Lavin MF, Poirier GG. Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP‐ribose)‐ dependent pathway in the early response to DNA‐damaging agents.”
BackgroundInfluentialThe PARP3- and ATM-dependent phosphorylation of APLF facilitates DNA double-strand break repair
Fenton, A. L., Shirodkar, P., Macrae, C. J., Meng, L., & Koch, C. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt134 · Cited by 66
“Although some reports in the literature suggest that early ATM signalling may be modulated by PAR (36), other studies have demonstrated that PARP inhibition does not affect ATM activity and in fact might even enhance it (33,39).”
Meyer‐Ficca, M. L., Lonchar, J. D., Credidio, C., Ihara, M., Li, Y., Wang, Z., & Meyer, R. G. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.075390 · Cited by 87
“PARP1, PAR, and ATM physically interact to mediate H2AFX phosphorylation, and it has been shown that c-H2AFX formation is delayed and reduced in Parp1 / fibroblasts [31].”
BackgroundToward understanding genomic instability, mitochondrial dysfunction and aging
Fakouri, N. B., Hou, Y., Demarest, T. G., Christiansen, L. S., Okur, M. N., Mohanty, J. G., Croteau, D. L., & Bohr, V. A. (2019) · The FEBS Journal · doi:10.1111/febs.14663 · Cited by 77
Rajawat, J., Shukla, N., & Mishra, D. P. (2017) · Medicinal Research Reviews · doi:10.1002/med.21442 · Cited by 77
Anthocyanins/anthocyanidins and colorectal cancer: What is behind the scenes?
Moraes, L. F. D. S., Sun, X., Pelúzio, M. D. C. G., & Zhu, M. J. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1357533 · Cited by 79
Development of Synthetic Lethality Anticancer Therapeutics
Fang, B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500415t · Cited by 82
Regulation of FOXO1-mediated transcription and cell proliferation by PARP-1
Sakamaki, J.-I., Daitoku, H., Yoshimochi, K., Miwa, M., & Fukamizu, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.022 · Cited by 71
Faraoni, I., Compagnone, M., Lavorgna, S., Angelini, D. F., Cencioni, M. T., Piras, E., Panetta, P., Ottone, T., Dolci, S., Venditti, A., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.001 · Cited by 76
Schweikl, H., Petzel, C., Bolay, C., Hiller, K., Buchalla, W., & Krifka, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.044 · Cited by 64
Inflammatory and age-related pathologies in mice with ectopic expression of human PARP-1
Mangerich, A., Herbach, N., Hanf, B., Fischbach, A., Popp, O., Moreno‐Villanueva, M., Bruns†, O. T., & Bürkle, A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.005 · Cited by 67
“…et al., 2008; d’Adda di Fagagna et al., 1999) and in the regulation of various proteins which are associated with aging including WRN, p53, ATM, and DNA-PK (Aguilar Quesada et al., 2007; Haince et al., 2007; Kanai et al., 2007; Ruscetti et al., 1998; von Kobbe et al., 2003; von Kobbe et al., 2004).”
BackgroundFahrer, J., Popp, O., Malanga, M., Beneke, S., Markovitz, D. M., Ferrando‐May, E., Bürkle, A., & Kappes, F. (2010) · Biochemistry · doi:10.1021/bi1004365 · Cited by 63
“indirectly activate the ATM signaling pathway (22).”
Deng, L., Lei, Q., Wang, Y., Wang, Z., Xie, G., Zhong, X., Wang, Y., Chen, N., Qiu, Y., Pu, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21561 · Cited by 65
Hekmatimoghaddam, S., Firoozabadi, A. D., Zare‐Khormizi, M. R., & Pourrajab, F. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.001 · Cited by 70
Leung, M., Rosen, D. B., Fields, S. Z., Cesano, A., & Budman, D. R. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00240 · Cited by 67
Gagné, J., Moreel, X., Gagné, P., Labelle, Y., Droit, A., Chevalier-Paré, M., Bourassa, S., McDonald, D., Hendzel, M. J., Prigent, C., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800810n · Cited by 67
Self-citationRole of poly(ADP-ribose) polymerase in sulfur mustard toxicity
Dębiak, M., Kehe, K., & Bürkle, A. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.002 · Cited by 60
Chen, J.-K., Lin, W.-L., Chen, Z., & Liu, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713912115 · Cited by 70
“Since both ATM and the MRN complex bind PAR polymer (53, 54), the PAR polymer on PARylated CIRBP may interact with ATM and the MRN complex and thereby facilitate their association with chromatin.”
BackgroundOlaparib in the management of ovarian cancer
Bixel, K. L., & Hays, J. L. (2015) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s62809 · Cited by 60
Yang, F., Baumann, C., & Fuente, R. D. L. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.05.550 · Cited by 60
“Consistent with this hypothesis, activation of the ataxia-telangiectasia-mutated (ATM) kinase and subsequent H2AX phophorylation can also take place in response to changes in chromatin structure that is independent of DSB formation (Bakkenist and Kastan, 2003; Haince et al., 2007).”
Signaling molecules in sulfur mustard-induced cutaneous injury.
Ruff, A. L., & Dillman, J. F. (2007) · PubMed Central · Cited by 57
Palma, J. P., Rodriguez, L. E., Bontcheva-Diaz, V., Bouska, J. J., Bukofzer, G. T., Colón-López, M. S., Guan, R., Jarvis, K., Johnson, E. F., Klinghofer, V., et al. (2008) · PubMed · Cited by 56
Metadata
- Authors
- Haince, J.-F., Kozlov, S., Dawson, V. L., Dawson, T. M., Hendzel, M. J., Lavin, M. F., & Poirier, G. G.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- QIMR Berghofer Medical Research Institute (AU)
- Johns Hopkins University (US)
- University of Alberta (CA)
- Corresponding author
- Poirier, Guy G.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 282
- Issue
- 22
- Pages
- 16441-16453
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2019775979
- Cited by
- 261
- References
- 61
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 4 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 18 · 2016: 16 · 2015: 20 · 2014: 21 · 2013: 18 · 2012: 20
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4873 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Neurological Disorders and Stroke (NS 39148, P01NS039148)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Keywords
- ATM kinase, poly(ADP-ribosyl)ation, PARP1, DNA damage response, p53 phosphorylation, H2AX phosphorylation, PARP inhibitors, chromatin remodeling, DNA repair, cell cycle checkpoints
- MeSH terms
- Poly (ADP-Ribose) Polymerase-1, Structural Maintenance of Chromosome Protein 1, Animals, Cell Line, Transformed, Chromosomal Proteins, Non-Histone, DNA Damage, DNA-Binding Proteins, Histones, Humans, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Protein Processing, Post-Translational, Signal Transduction, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Mice, Knockout, Cell Cycle Proteins, Tumor Suppressor Proteins, Chromatin Assembly and Disassembly, Cell Line, Tumor, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.